MIRA Pharmaceuticals, Inc. (MIRA)
(Delayed Data from NSDQ)
$1.20 USD
+0.01 (0.84%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $1.20 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About PS Ratio (TTM)
The Price to Sales ratio or P/S is calculated as price divided by sales for the past 12 months. After the P/E ratio, it's one of the most common valuation metrics.
MIRA 1.20 +0.01(0.84%)
Will MIRA be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for MIRA based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for MIRA
Mira Pharmaceuticals initiated with bullish view at Rodman & Renshaw, here's why
MIRA Pharmaceuticals Announces New Preclinical Data for Ketamir-2 to Be Presented at the 18th Annual Pain Therapeutics Summit in Boston on October 28-29, 2024
Mira Pharmaceuticals presents preclinical data for Ketamir-2
Mira Pharmaceuticals advances Ketamir-2 development
MIRA Pharmaceuticals Advances Ketamir-2 Development Following Phase 1 Design Completion, Focusing on Early Clinical Efficacy Demonstration for Neuropathic Pain in 2025